Skip to main content
OpenTrials
Completed

NCT Number: NCT02535728

Anesthesia Geriatric Evaluation and Quality of Life After Cardiac Surgery

A prospective observational cohort study to assess the predictive value of preoperative frailty on postoperative quality of life in cardiac surgery patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

70 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

St Antonius hospital

Nieuwegein, Utrecht, 3435 CM, Netherlands

About this study

Introduction:

The current population is ageing in a rapid pace. Currently elderly represent 17.8% of the Dutch population. Most recent estimates show this will increase to 25.6% 20 years' time. This rise in elderly will also reflect on the population of patients being referred for cardiac surgery. Especially elderly patients are at risk for postoperative complications, mortality or functional decline. In frail elderly this effect might be more pronounced. Frailty is an umbrella term that encompasses patient related factors such as weight loss, muscle wasting, inactivity, comorbidities and polypharmacy. Current scoring systems that are used to predict postoperative mortality and complications following cardiac surgery perform poorly in the elderly population and do not take into account frailty. Moreover they are designed to predict mortality and complications and are not validated to predict patient reported outcome measures such as quality of life or functional status. The aim of the AGE study is assess the value of frailty factors in predicting an improvement in quality of life one year after cardiac surgery.

Methods:

The AGE study is a prospective observational cohort study. All patients aged 70 years or older, scheduled for cardiac surgery, mentally competent and have signed informed consent are eligible for the study. During routine preoperative screening patients will be screened for frailty using different questionnaires and physical tests. The battery of tests exist of Short Form 36 (SF36), Multi Nutritional Assessment (MNA), Mini Mental State Examination (MMSE) and Nagi's scale for disability, Three physical tests: five meter walking speed, timed get up and go test and hand grip strength. A non-invasive measurement of Advanced Glycation Endproducts (AGEs) and a medication review. A blood sample will be taken to determine vitamin status, iron deficiency, pre-operative inflammatory parameters, CMV status, pneumococcal carriage and cardiac biomarkers. After surgery electronic patients charts will be studied to score postoperative complications or mortality. Three months and one year after cardiac surgery patients will receive SF-36 and World Health Organization Disability Assessment Schedule (WHODAS) 2.0 questionnaires to determine quality of life and functional status.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 70 years or older
  • Mentally competent
  • Planned cardiac surgery (coronary, valvular, rhythm, aortic or combination of those)
  • Signed informed consent

Treatment and study plan

Primary outcomes

  1. Quality of Life Assessed by Short Form-36 (SF-36)

    Time frame: 12 months after surgery

    Assessed by Short Form-36 (SF-36)

Secondary outcomes

  1. Quality of Life Assessed by Short Form-36 (SF-36)

    Time frame: 3 months after surgery

    Assessed by Short Form-36 (SF-36)

  2. Psychosocial or physical functioning Assessed by World Health Organisation Disability Assessment Schedule 2.0

    Time frame: 3 and 12 months after surgery

    Assessed by World Health Organisation Disability Assessment Schedule 2.0 (WHODAS 2.0)

  3. Incidence of postoperative complications

    Time frame: 30 days after surgery

    Postoperative complications are scored according to Dutch national guidelines on reporting complications in cardiac surgery and include rethoracotomy, reoperation, bleeding, arrythmia, stroke, myocardial infarction, deep sternal wound infection, pneumonia, urinary tract infection, sepsis, respiratory insufficiency, prolonged respiratory support and renal failure (AKI).

  4. Mortality

    Time frame: 30 days and 12 months after surgery

  5. Length of stay in hospital and ICU

    Time frame: Post-Surgery. The expected length of stay in the ICU is 1 to 5 days and in hospital 5 to 10 days.

  6. Postoperative delirium

    Time frame: 30 days

    Delirium according to intensive care delirium screening (ICDSC) or delirium observation screening (DOS)

Sponsors and collaborators

Lead sponsor

St. Antonius Hospital

Other

Registry information

Official study title

Anesthesia Geriatric Evaluation and the Prediction of Quality of Life in Elderly Cardiac Surgery Patients

Acronym: AGE

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Aug 31, 2015
Registry last updated
Mar 6, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.